Okay, Computer: Ro CEO Zach Reitano on Weight Loss Drugs
RiskReversal Pod
00:00
The Cardiometabolic Revolution
There's such unprecedented demand, I think we're going to see shortages through the end of the year. Novo has said that by September, they expect the shortage to subside. And so my hope is that we'll both lead to a reduction in supply shortages, but also price compression over time. We are at the very, very beginning of this cardiometabolic revolution.
Play episode from 18:28
Transcript
